Advanced Cell Models – Webinars and Online Events

Join our expert speaker, whose research centers around patient-derived organoid models, to discuss key considerations of clinically sourced gut epithelial tissue and molecular profiling.

This webinar explores how the XF Flex analyzer – a cutting-edge metabolic analysis platform – is specifically designed to overcome these obstacles, offering enhanced flexibility and optimized workflows for functional metabolic studies in 3D models, e

During this interactive session, Dr. Hartung will discuss how organoids (miniature, lab-grown versions of organs) are transforming personalized medicine, drug screening and disease modeling.

This webinar will explore the landscape of organoid research, highlighting the latest technological advances, such as AI and automation, that are shaping the field.

This event will cover innovations in advanced in vitro and in vivo disease modeling and how these advancements are accelerating drug discovery, personalized medicine and our understanding of complex disease mechanisms.

This webinar will explore how automating parts of the cell differentiation process and implementing quality assurance steps can streamline organoid production and make it more scalable and reliable for broader applications.

Join Prof. Michael L. Shuler for a live session on "Body-on-a-Chip" technology. Discover its role in drug discovery, toxicity testing and disease modeling, plus insights into its future.

The increasing implication of glial cells in neurodegenerative diseases makes them an appealing addition to iPSC-based model systems for investigating disease mechanisms.

Explore the tools and techniques being used to study diseases in the lab. Discover how advances in cell culture and disease modeling are supporting diagnostic and therapeutic development.

This online event is aimed at those working within academia and pharmaceutical drug development, who want to hear from experts across their field. Focus will be given to the latest advances in small molecule drug discovery and development, biopharma and biotechnology.